Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease

被引:5
|
作者
Huang, Xiaoli [1 ]
Cheng, Yimin [2 ]
Wang, Na [1 ]
机构
[1] Xian Hosp Tradit Chinese Med, Dept Cardiovascol, 69 Fengcheng Eighth Rd, Xian 710021, Peoples R China
[2] Hosp Xian Shiyou Univ, Dept Obstet & Gynecol, Xian 710065, Peoples R China
关键词
Coronary heart disease; Polymorphisms; Susceptibility; Gene; POLYMORPHISMS; RISK;
D O I
10.1186/s12920-022-01307-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Genetic factors are important risk factors to develop coronary heart disease (CHD). In this study, we mainly explored whether CYP11B1 mutations influence CHD risk among Chinese Han population. Methods Six variants were genotyped using Agena MassARRAY system from 509 CHD patients and 509 healthy controls. The correlations between CYP11B1 mutations and CHD risk were assessed using odds ratio (OR) and 95% confidence interval (95% CI) by logistic regression. The haplotype analysis and were ultifactor dimensionality reduction (MDR) were conducted. Results In the overall analysis, CYP11B1 polymorphisms were not correlated with CHD susceptibility. In the stratified analysis, we found that rs5283, rs6410, and rs4534 are significantly associated with susceptibility to CHD dependent on age and gender (p < 0.05). Moreover, we also observed that rs5283 and rs4534 could affect diabetes/hypertension risk among CHD patients (p < 0.05). In addition, the C(rs4736312)A(rs5017238)C(rs5301)G(rs5283)T(rs6410)C(rs4534) haplotype of CYP11B1 reduce the susceptibility to CHD (p < 0.05). Conclusions We found that rs4534, rs6410 and rs5283 in CYP11B1 gene influence the susceptibility to CHD, which depend on age and gender.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews
    Paperna, T
    Gershoni-Baruch, R
    Badarneh, K
    Kasinetz, L
    Hochberg, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (09): : 5463 - 5465
  • [42] A high rate of novel CYP11B1 mutations in Saudi Arabia
    Alzahrani, Ali S.
    Alswailem, Meshael M.
    Murugan, Avaniyapuram Kannan
    Alhomaidah, Doha S.
    Capper, Cameron P.
    Auchus, Richard J.
    Qasem, Ebtesam
    Alzahrani, Ohoud S.
    Al-Sagheir, Afaf
    Bin-Abbas, Bassam
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 174 : 217 - 224
  • [43] Cyp11b1 Null Mouse, a Model of Congenital Adrenal Hyperplasia
    Mullins, Linda J.
    Peter, Audrey
    Wrobel, Nicola
    McNeilly, Judith R.
    McNeilly, Alan S.
    Al-Dujaili, Emad A. S.
    Brownstein, David G.
    Mullins, John J.
    Kenyon, Christopher J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (06) : 3925 - 3934
  • [44] Mutations in CYP11B1 gene:: Phenotype-genotype correlations
    Zhu, YS
    Cordero, JJ
    Can, S
    Cai, LQ
    You, XK
    Herrera, C
    DeFillo-Ricart, M
    Shackleton, C
    Imperato-McGinley, J
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 122A (03): : 193 - 200
  • [45] Mechanisms for transcriptional activation of rat CYP11B1 gene by adrenocorticotropin
    Mukai, K
    Agake, R
    Mitani, F
    Ishimura, Y
    FASEB JOURNAL, 1997, 11 (09): : A798 - A798
  • [46] Molecular analysis of 12 Chinese patients with 11β-hydroxylase deficiency and in vitro functional study of 20 CYP11B1 missense variants
    Sun, Bang
    Lu, Lin
    Xie, Shaowei
    Zhang, Wei
    Zhang, Xiaoxia
    Tong, Anli
    Chen, Shi
    Wu, Xueyan
    Mao, Jiangfeng
    Wang, Xi
    Qiu, Ling
    Nie, Min
    FASEB JOURNAL, 2023, 37 (04):
  • [47] In silico and in vitro workflow to identify pharmaceuticals inhibiting CYP17A1 and CYP11B1
    Jager, M. -C.
    Kedzierski, J.
    Gell, V.
    Wey, T.
    Naem, S.
    Winter, D. V.
    Schuster, D.
    Smiesko, M.
    Odermatt, A.
    TOXICOLOGY LETTERS, 2023, 384 : S190 - S190
  • [48] Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 Inhibitors
    Papillon, Julien P. N.
    Adams, Christopher M.
    Hu, Qi-Ying
    Lou, Changgang
    Singh, Alok K.
    Zhang, Chun
    Carvalho, Jose
    Rajan, Srinivan
    Amaral, Adam
    Beil, Michael E.
    Fu, Fumin
    Gangl, Eric
    Hu, Chii-Whei
    Jeng, Arco Y.
    LaSala, Daniel
    Liang, Guiqing
    Logman, Michael
    Maniara, Wieslawa M.
    Rigel, Dean F.
    Smith, Sherri A.
    Ksander, Gary M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (11) : 4749 - 4770
  • [49] Regulation of human CYP11B1 and CYP11B2 promoters by transposable elements and conserved cis elements
    Cheng, Li-Chuan
    Pai, Tun-Wen
    Li, Lih-Ann
    STEROIDS, 2012, 77 (1-2) : 100 - 109
  • [50] Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production
    Nicod, M
    Dick, B
    Frey, FJ
    Ferrari, P
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 214 (1-2) : 167 - 174